Top

Quality of Life Research

Gepubliceerd in:

25-02-2017

Patient-reported symptoms of radiation dermatitis during breast cancer radiotherapy: a pilot study

Auteurs: Jieun Lee, Won Park, Doo Ho Choi, Seung Jae Huh, Im-Ryung Kim, Danbee Kang, Juhee Cho

Gepubliceerd in: Quality of Life Research | Uitgave 7/2017

Abstract

Purpose

To find out which symptoms most frequently and severely affect breast cancer patients during radiotherapy and how patients manage the symptoms and unmet needs.

Methods

A cross-sectional survey was conducted with 111 patients who receive radiotherapy for breast cancer from January to April 2015 at Samsung Medical Center in Seoul, South Korea. Participants were asked about symptoms and discomfort due to radiotherapy, management methods for radiation dermatitis, unmet needs for radiation dermatitis care, and clinical and socio-demographic information.

Results

Of total, 108 out of 111 patients (97.3%) reported symptoms related to radiation dermatitis. Hyperpigmentation was the most commonly reported uncomfortable symptom followed by erythema. On average, patients reported 8.6 radiotherapy-induced skin problems (range, 0–11). Of total, 59 (53.2%) patients stated that they wanted care for radiation dermatitis, and 80.0, 59.4, and 51% of patients searched for information, used products, and visited the hospital to manage radiotherapy-related skin problems. Patients who experienced dryness, burning feelings, irritation, roughness, and hyperpigmentation were 11.73, 7.02, 5.10, 4.27, and 2.80 times more likely to have management needs than patients without those symptoms, respectively, adjusting age, current cycle of radiation therapy, chemotherapy, and type of surgery.

Conclusions

Most of the breast cancer patients experience multiple symptoms associated with radiation dermatitis. Hyperpigmentation was the most common and uncomfortable symptom followed by erythema. Majority of patients wanted management for radiation dermatitis and patients who experienced dryness, burning feelings, irritation, roughness, and hyperpigmentation had higher needs for radiation dermatitis management.

vorige artikel The prognostic value of pre-diagnosis health-related quality of life on survival: a prospective cohort study of older Americans with lung cancer

volgende artikel Electronic patient-reported outcomes and toxicities during radiotherapy for head-and-neck cancer

Waghmare, C. M. (2013). Radiation burn–from mechanism to management. Burns, 39(2), 212–219.CrossRefPubMed

Ha, B., Suh, H. S., Lee, J., Lee, K. J., Lee, R., & Moon, B. I. (2013). Long-term results of forward intensity-modulated radiation therapy for patients with early-stage breast cancer. Radiation Oncology Journal, 31(4), 191–198.CrossRefPubMedPubMedCentral

Hymes, S. R., Strom, E. A., & Fife, C. (2006). Radiation dermatitis: Clinical presentation, pathophysiology, and treatment 2006. Journal of the American Academy of Dermatology, 54(1), 28–46.CrossRefPubMed

Chan, R. J., Webster, J., Chung, B., Marquart, L., Ahmed, M., & Garantziotis, S. (2014). Prevention and treatment of acute radiation-induced skin reactions: A systematic review and meta-analysis of randomized controlled trials. BMC Cancer, 14, 53.CrossRefPubMedPubMedCentral

Neben-Wittich, M. A., Atherton, P. J., Schwartz, D. J., Sloan, J. A., Griffin, P. C., Deming, R. L., Anders, J. C., Loprinzi, C. L., Burger, K. N., Martenson, J. A., & Miller, R. C. (2011). Comparison of provider-assessed and patient-reported outcome measures of acute skin toxicity during a Phase III trial of mometasone cream versus placebo during breast radiotherapy: The North Central Cancer Treatment Group (N06C4). International Journal of Radiation Oncology, Biology, Physics, 81(2), 397–402.CrossRefPubMed

Basch, E., Iasonos, A., McDonough, T., Barz, A., Culkin, A., Kris, M. G., Scher, H. I., & Schrag, D. (2006). Patient versus clinician symptom reporting using the National Cancer Institute Common Terminology Criteria for Adverse Events: results of a questionnaire-based study. The Lancet Oncology, 7(11), 903–909.CrossRefPubMed

Chen, A. P., Setser, A., Anadkat, M. J., Cotliar, J., Olsen, E. A., Garden, B. C., & Lacouture, M. E. (2012). Grading dermatologic adverse events of cancer treatments: the Common Terminology Criteria for Adverse Events Version 4.0. Journal of the American Academy of Dermatology, 67(5), 1025–1039.CrossRefPubMed

Harsolia, A., Kestin, L., Grills, I., Wallace, M., Jolly, S., Jones, C., Lala, M., Martinez, A., Schell, S., & Vicini, F. A. (2007). Intensity-modulated radiotherapy results in significant decrease in clinical toxicities compared with conventional wedge-based breast radiotherapy. International Journal of Radiation Oncology, Biology, Physics, 68(5), 1375–1380.CrossRefPubMed

Kang, H. C., Ahn, S. D., Choi, D. H., Kang, M. K., Chung, W. K., & Wu, H. G. (2014). The safety and efficacy of EGF-based cream for the prevention of radiotherapy-induced skin injury: results from a multicenter observational study. Radiation Oncology Journal, 32(3), 156–162.CrossRefPubMedPubMedCentral

10.

Faithfull, S., Lemanska, A., & Chen, T. (2015). Patient-reported outcome measures in radiotherapy: Clinical advances and research opportunities in measurement for survivorship. Clinical Oncology, 27(11), 679–685.CrossRefPubMed

11.

FDA. (2006). Draft guidance for industry on patient-reported outcome measures: Use in medicinal product development to support labeling claims. Fed Register, 71, 5862–5863.

12.

Kluetz, P. G., Chingos, D. T., Basch, E. M., & Mitchell, S. A. (2016). Patient-reported outcomes in cancer clinical trials: Measuring symptomatic adverse events with the national cancer institute’s patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE). American Society of Clinical Oncology Educational Book, 35, 67–73.CrossRefPubMed

13.

Vacek, P. M., Winstead-Fry, P., Secker-Walker, R. H., Hooper, G. J., & Plante, D. A. (2003). Factors influencing quality of life in breast cancer survivors. Quality of Life Research, 12(5), 527–537.CrossRefPubMed

14.

Harris, R., Probst, H., Beardmore, C., James, S., Dumbleton, C., Bolderston, A., Faithfull, S., Wells, M., & Southgate, E. (2012). Radiotherapy skin care: A survey of practice in the UK. Radiography, 18(1), 21–27.CrossRef

15.

O’Donovan, A., Coleman, M., Harris, R., & Herst, P. (2015). Prophylaxis and management of acute radiation-induced skin toxicity: a survey of practice across Europe and the USA. European Journal of Cancer Care, 24(3), 425–435.CrossRefPubMed

16.

Bolderston, A., Lloyd, N. S., Wong, R. K., Holden, L., Robb-Blenderman, L., & Supportive Care Guidelines Group of Cancer Care Ontario Program in Evidence-Based, C. (2006). The prevention and management of acute skin reactions related to radiation therapy: a systematic review and practice guideline. Support Care Cancer, 14(8), 802–817.CrossRefPubMed

17.

Atherton, P. J., Burger, K. N., Loprinzi, C. L., Neben Wittich, M. A., Miller, R. C., Jatoi, A., & Sloan, J. A. (2012). Using the Skindex-16 and common terminology criteria for adverse events to assess rash symptoms: Results of a pooled-analysis (N0993). Supportive Care in Cancer, 20(8), 1729–1735.CrossRefPubMed

18.

Huang, C. J., Hou, M. F., Luo, K. H., Wei, S. Y., Huang, M. Y., Su, S. J., Kuo, H. Y., Yuan, S. S., Chen, G. S., Chu-Sung Hu, S., & Chuang, H. Y. (2015). RTOG, CTCAE and WHO criteria for acute radiation dermatitis correlate with cutaneous blood flow measurements. Breast, 24(3), 230–236.CrossRefPubMed

19.

Bottomley, A., Jones, D., & Claassens, L. (2009). Patient-reported outcomes: Assessment and current perspectives of the guidelines of the Food and Drug Administration and the reflection paper of the European Medicines Agency. European Journal of Cancer, 45(3), 347–353.CrossRefPubMed

20.

Kumar, S., Juresic, E., Barton, M., & Shafiq, J. (2010). Management of skin toxicity during radiation therapy: A review of the evidence. Journal of Medical Imaging and Radiation Oncology, 54(3), 264–279.CrossRefPubMed

21.

Rutqvist, L. E., Rose, C., & Cavallin-ståhl, E. (2003). A systematic overview of radiation therapy effects in breast cancer. Acta Oncologica, 42(5–6), 532–545.CrossRefPubMed

22.

Szumacher, E., Wighton, A., Franssen, E., Chow, E., Tsao, M., Ackerman, I., Andersson, L., Kim, J., Wojcicka, A., Ung, Y., Sixel, K., & Hayter, C. (2001). Phase II study assessing the effectiveness of Biafine cream as a prophylactic agent for radiation-induced acute skin toxicity to the breast in women undergoing radiotherapy with concomitant CMF chemotherapy. International Journal of Radiation Oncology, Biology, Physics, 51(1), 81–86.CrossRefPubMed

23.

McGale, P., Taylor, C., Correa, C., Cutter, D., Duane, F., Ewertz, M., Gray, R., Mannu, G., Peto, R., Whelan, T., Wang, Y., Wang, Z., & Darby, S. (2014). Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials. Lancet, 383(9935), 2127–2135.CrossRefPubMed

24.

Darby, S., McGale, P., Correa, C., Taylor, C., Arriagada, R., Clarke, M., Cutter, D., Davies, C., Ewertz, M., Godwin, J., Gray, R., Pierce, L., Whelan, T., Wang, Y., & Peto, R. (2011). Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials. Lancet, 378(9804), 1707–1716.CrossRefPubMed

25.

Lee, S. Y., Kwon, H. C., Kim, J. S., & Lee, H.-K. (2010). An analysis of the incidence and related factors for radiation dermatitis in breast cancer patients who received radiation therapy. The Journal of the Korean Society for Therapeutic Radiology and Oncology, 28(1), 16.CrossRef

26.

Harper, J. L., Franklin, L. E., Jenrette, J. M., & Aguero, E. G. (2004). Skin toxicity during breast irradiation: pathophysiology and management. Southern Medical Journal, 97(10), 989–993.CrossRefPubMed

27.

Vogelzang, N. J., Breitbart, W., Cella, D., Curt, G. A., Groopman, J. E., Horning, S. J., Itri, L. M., Johnson, D. H., Scherr, S. L., & Portenoy, R. K. (1997). Patient, caregiver, and oncologist perceptions of cancer-related fatigue: results of a tripart assessment survey. The Fatigue Coalition. Seminars in Hematology, 34(3 Suppl 2), 4–12.PubMed

28.

Fromme, E. K., Eilers, K. M., Mori, M., Hsieh, Y. C., & Beer, T. M. (2004). How accurate is clinician reporting of chemotherapy adverse effects? A comparison with patient-reported symptoms from the Quality-of-Life Questionnaire C30. Journal of Clinical Oncology 22(17), 3485–3490.CrossRefPubMed

29.

Patrick, D. L., Ferketich, S. L., Frame, P. S., Harris, J. J., Hendricks, C. B., Levin, B., Link, M. P., Lustig, C., McLaughlin, J., Ried, L. D., Turrisi, A. T. 3rd, Unutzer, J., & Vernon, S. W. (2003). National institutes of health state-of-the-science conference statement: Symptom management in cancer: Pain, depression, and fatigue, July 15–17, 2002. Journal of the National Cancer Institute, 95(15), 1110–1117.CrossRefPubMed

30.

Noh, J. M., Choi, D. H., Park, H., Huh, S. J., Park, W., Seol, S. W., Jeong, B. K., Nam, S. J., Lee, J. E., & Kil, W. H. (2014). Comparison of acute skin reaction following morning versus late afternoon radiotherapy in patients with breast cancer who have undergone curative surgical resection. Journal of Radiation Research, 55(3), 553–558.CrossRefPubMedPubMedCentral

31.

Montazeri, A. (2008). Health-related quality of life in breast cancer patients: a bibliographic review of the literature from 1974 to 2007. Journal of Experimental & Clinical Cancer Research: CR, 27, 32.CrossRefPubMedCentral

32.

Ebanks, J. P., Wickett, R. R., & Boissy, R. E. (2009). Mechanisms regulating skin pigmentation: the rise and fall of complexion coloration. The International Journal of Molecular Sciences, 10(9), 4066–4087.CrossRefPubMed

33.

McQuestion, M. (2006). Evidence-based skin care management in radiation therapy. Seminars in Oncology Nursing, 22(3), 163–173.CrossRefPubMed

34.

Lee, J. H., Kay, C. S., Maeng, L. S., Oh, S. J., Lee, A. H., Lee, J. D., Han, C. W., & Cho, S. H. (2009). The clinical features and pathophysiology of acute radiation dermatitis in patients receiving tomotherapy. Annals of Dermatology, 21(4), 358–363.CrossRefPubMedPubMedCentral

35.

Hu, S. C., Hou, M. F., Luo, K. H., Chuang, H. Y., Wei, S. Y., Chen, G. S., Chiang, W., & Huang, C. J. (2014). Changes in biophysical properties of the skin following radiotherapy for breast cancer. The Journal of Dermatology, 41(12), 1087–1094.CrossRefPubMed

36.

Salvo, N., Barnes, E., van Draanen, J., Stacey, E., Mitera, G., Breen, D., Giotis, A., Czarnota, G., Pang, J., & De Angelis, C. (2010). Prophylaxis and management of acute radiation-induced skin reactions: a systematic review of the literature. Current Oncology, 17(4), 94–112.PubMedPubMedCentral

37.

Richardson, J., Smith, J. E., McIntyre, M., Thomas, R., & Pilkington, K. (2005). Aloe Vera for preventing radiation-induced skin reactions: A systematic literature review. Clinical Oncology, 17(6), 478–484.CrossRefPubMed

Titel: Patient-reported symptoms of radiation dermatitis during breast cancer radiotherapy: a pilot study
Auteurs: Jieun Lee
Won Park
Doo Ho Choi
Seung Jae Huh
Im-Ryung Kim
Danbee Kang
Juhee Cho
Publicatiedatum: 25-02-2017
Uitgeverij: Springer International Publishing
Gepubliceerd in: Quality of Life Research / Uitgave 7/2017
Print ISSN: 0962-9343
Elektronisch ISSN: 1573-2649
DOI: https://doi.org/10.1007/s11136-017-1526-4

Bohn Stafleu van Loghum

Deel dit onderdeel of sectie (kopieer de link)

Abstract

Purpose

Methods

Results

Conclusions

Log in om toegang te krijgen

Andere artikelen Uitgave 7/2017

Examining health-related quality of life patterns in women with breast cancer

Utility scores for different health states related to depression: individual participant data analysis

Understanding burden of illness for child growth hormone deficiency

Electronic patient-reported outcomes and toxicities during radiotherapy for head-and-neck cancer

The Weiss Functional Impairment Rating Scale-Parent Form for assessing ADHD: evaluating diagnostic accuracy and determining optimal thresholds using ROC analysis

Changes in quality of life from a homelessness intervention: true change, response shift, or random variation